Amyotrophic lateral sclerosis (ALS) is a multifactorial, multisystem motor neuron disease for which currently there is no effective treatment. There is an urgent need to identify biomarkers to tackle the disease's complexity and help in early diagnosis, prognosis, and therapy. Extracellular vesicles (EVs) are nanostructures released by any cell type into body fluids. Their biophysical and biochemical characteristics vary with the parent cell's physiological and pathological state and make them an attractive source of multidimensional data for patient classification and stratification
Extracellular vesicles (EVs) are cell-derived nanoparticles, involved in cell-to-cell communication,...
Amyotrophic lateral sclerosis (ALS) is a terminalneurodegenerative disease. Clinical and molecular o...
Extracellular vesicles are recently described as specialized structures for intercellular communicat...
Abstract Background Amyotrophic lateral sclerosis (ALS) is a multifactorial, multisystem motor neuro...
Amyotrophic lateral sclerosis (ALS) is described as a fatal and rapidly progressive neurodegenerativ...
Amyotrophic Lateral Sclerosis is a progressive neurodegenerative disease and is the most common adul...
Extracellular vesicles can mediate communication between tissues, affecting the physiological condit...
Amyotrophic lateral sclerosis (ALS) is a progressive adult-onset neurodegenerative disease, that aff...
<p>Amyotrophic lateral sclerosis (ALS) is a progressive adult-onset neurodegenerative disease, that ...
Amyotrophic Lateral Sclerosis (ALS) is a neurodegenerative disease characterized by the deposition o...
Background Extracellular vesicles (EVs) released by neurons and glia reach the cerebrospinal fluid (...
Reliable markers of diagnosis, disease activity and progression in neurodegenerative diseases are a ...
BACKGROUND: The cause of the motor neuron (MN) death that drives terminal pathology in amyotrophic l...
Extracellular vesicles have been identified as pivotal mediators of intercellular communication with...
Extracellular vesicles (EVs), nanoparticles originated from different cell types, seem to be implica...
Extracellular vesicles (EVs) are cell-derived nanoparticles, involved in cell-to-cell communication,...
Amyotrophic lateral sclerosis (ALS) is a terminalneurodegenerative disease. Clinical and molecular o...
Extracellular vesicles are recently described as specialized structures for intercellular communicat...
Abstract Background Amyotrophic lateral sclerosis (ALS) is a multifactorial, multisystem motor neuro...
Amyotrophic lateral sclerosis (ALS) is described as a fatal and rapidly progressive neurodegenerativ...
Amyotrophic Lateral Sclerosis is a progressive neurodegenerative disease and is the most common adul...
Extracellular vesicles can mediate communication between tissues, affecting the physiological condit...
Amyotrophic lateral sclerosis (ALS) is a progressive adult-onset neurodegenerative disease, that aff...
<p>Amyotrophic lateral sclerosis (ALS) is a progressive adult-onset neurodegenerative disease, that ...
Amyotrophic Lateral Sclerosis (ALS) is a neurodegenerative disease characterized by the deposition o...
Background Extracellular vesicles (EVs) released by neurons and glia reach the cerebrospinal fluid (...
Reliable markers of diagnosis, disease activity and progression in neurodegenerative diseases are a ...
BACKGROUND: The cause of the motor neuron (MN) death that drives terminal pathology in amyotrophic l...
Extracellular vesicles have been identified as pivotal mediators of intercellular communication with...
Extracellular vesicles (EVs), nanoparticles originated from different cell types, seem to be implica...
Extracellular vesicles (EVs) are cell-derived nanoparticles, involved in cell-to-cell communication,...
Amyotrophic lateral sclerosis (ALS) is a terminalneurodegenerative disease. Clinical and molecular o...
Extracellular vesicles are recently described as specialized structures for intercellular communicat...